Tissue renin-angiotensin system in myocardial hypertrophy and failure

Arch Intern Med. 1993 Apr 26;153(8):937-42.

Abstract

The renin-angiotensin system traditionally has been conceived as a neuroendocrine system functioning in the circulation. Recent research has confirmed the existence of autocrine/paracrine tissue renin-angiotensin systems present and functioning at multiple sites, including cardiac, vascular, and renal tissues, which contain the majority of angiotensin-converting enzyme in the body. It appears that the circulating renin-angiotensin system is activated acutely to maintain homeostasis and is then turned off at cardiovascular compensation, while the tissue renin-angiotensin systems exert long-term actions that affect cardiovascular function and structure, which may play a pathophysiological role in congestive heart failure, hypertension, and vascular disease and influence the response to therapy with angiotensin-converting enzyme-inhibiting agents.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Cardiomegaly / physiopathology*
  • Heart Failure / physiopathology*
  • Humans
  • Peptidyl-Dipeptidase A / physiology*
  • Renin-Angiotensin System / physiology*

Substances

  • Peptidyl-Dipeptidase A